期刊文献+

2型糖尿病126例临床用药分析 被引量:2

下载PDF
导出
摘要 目的:了解我院2型糖尿病患者用药情况。方法:对我院126份已确定的2糖尿病患者的资料进行回顾性分析。结果:2型糖尿病多采用联合用药的方法治疗,合用2种降糖药62例,占49.21%,在调查的126份2糖尿病资料中,格列齐特使用频率最高,占80.95%。糖尿病慢性并发症的发病率有52例,占41.27%。结论:糖尿病患者应注重药物的联合使用原则、注意药物间的相互作用、糖尿病并发症的严重危害等,加强对糖尿病的合理用药。
机构地区 解放军第
出处 《中国药师》 CAS 2008年第1期82-84,共3页 China Pharmacist
  • 相关文献

参考文献6

二级参考文献19

  • 1[1]Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus[J].Diabetes Care 1999,22(Suppl 1):5-22
  • 2[2]Zimmerman BR,Diagnosis and classifications in Zimmerman BR,ed.Medical management of type 2 diabetes[M].4th ed.Alexandria,VA: American Diabetes Association; 1998:2-61
  • 3[4]Keilson L,Mather S,Walter YH et al.Synergistic effects of nateglinide and meal administration on insulin secretion in patients with type 2 diabetes mellitus[J].J Clin Endocrinol Metab,2000,85:1081-1086
  • 4[5]Hanefeld M,Bonter KP,Dikinson S,et al.Rapid and sbort-acting mealtime insulin secretion with nsteglinide controls both prandial and mean glycemia[J].Diabetes Care,2000,23:202-207
  • 5[6]Hanif W,Kumar S.Nateqlinide: a new rapid-acting insulinotropic agent[J].Expert Opin Pharmacother,2001,2(6): 1027-1031
  • 6[7]Kikuchi M.Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoqlycaemic agents,NN623 and A4166[J].Diabe Med,1996,13:151-155
  • 7[8]Hirschberg Y,Karara AH,Pietri AO,et al.Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin[J].Diaber Care.2000,23:349-353
  • 8[9]Hu S,Wang S.Effect of insulinotropic agents nateglinide on KV and Ca(2+) channels in pencreatic beta-cell[J].Eur J Pharmacob.2001,427(2) :94-104
  • 9[10]Karara AH,Dunning BE,Mcload JF.The effect of food on the oralbioavilability and the pharmacodynamic actions of the insulinotropic agent nateglinide in healthy subjects[J].J Clin Pharmacol,1999(2):39:171-179
  • 10[11]Luzio SD,Anderson Dm,Owens DR.Effects of timing of administration and meal composition on the pharmacokinetic and pharmacodynamic characteristics of the short-acting oral hypoglycemic agent nateglinide in healthy subjects [ J ].J Clin Endocrinol Medtab,2001,86(10) :4874-4880

共引文献41

同被引文献13

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部